Swiss National Bank
CRGX

Swiss National Bank’s CARGO Therapeutics CRGX Stock Holding History

Swiss National Bank’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,100
Closed -$147K – 2351
2025
Q1 		$147K Hold
36,100
– – ﹤0.01% 2396
2024
Q4 		$521K Buy
36,100
+5,300
+17% +$96.2K ﹤0.01% 2399
2024
Q3 		$568K Buy
30,800
+3,700
+14% +$66.2K ﹤0.01% 2406
2024
Q2 		$445K Sell
27,100
-1,400
-5% -$26.6K ﹤0.01% 2432
2024
Q1 		$636K Buy
+28,500
New +$678K ﹤0.01% 2405

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

Swiss National Bank's CRGX Position: Q2 2025 in Review

Swiss National Bank sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 36,100 shares — an estimated $147K sold.

Swiss National Bank first reported a position in CRGX in Q1 2024 and held it in 5 quarters. The position peaked at $636K in Q1 2024. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

  • Swiss National Bank reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Swiss National Bank sold 36,100 CARGO Therapeutics shares in Q2 2025, an estimated $147K.
  • Swiss National Bank first reported a position in CARGO Therapeutics in Q1 2024 and held it in 5 quarters.
  • Swiss National Bank's CARGO Therapeutics position peaked at $636K in Q1 2024.
  • 116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.